Literature DB >> 10675579

Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.

E Matsuura1, F Umehara, T Hashiguchi, N Fujimoto, Y Okada, M Osame.   

Abstract

Matrix metalloproteinases (MMPs) are believed to play an essential role in the breakdown of the extracellular matrix macromolecules in the blood-cerebrospinal fluid barrier and blood-brain barrier (BBB). In this study, the levels of MMP-2 and MMP-9 and their common tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) were measured in the cerebrospinal fluid (CSF) from patients with various meningitides including aseptic, fungal and tuberculous ones. MMP-9 production level in CSF was more increased in subacute meningitis including fungal and tuberculous meningitis than in acute aseptic meningitis and non-inflammatory neurological diseases (NIDs). Enhanced production of MMP-9 was associated with high proteolytic activity detected by gelatin zymography. The MMP-2 and TIMP-1 levels in CSF of subacute meningitis were also higher than those of NIDs. In contrast, the TIMP-2 levels in CSF of either acute aseptic or subacute meningitis were not up-regulated compared with those of NIDs. The central nervous system (CNS) complications (i.e. disturbance of consciousness, psychiatric symptoms, urinary disturbance, etc.) during the course of meningitis showed good correlation with the enhanced production of MMP-9 in CSF. Immunohistochemical studies in tuberculous meningitis demonstrated that the infiltrating mononuclear cells in the meninges were immunoreactive for both MMP-2 and MMP-9. However, the infiltrating mononuclear cells into CNS parenchyma had immunoreactivity for MMP-9, but not for MMP-2. Taken together, those data suggest that MMP-9 in CSF may be a useful marker of encephalitogenecity during the course of subacute meningitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675579     DOI: 10.1016/s0022-510x(99)00303-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  27 in total

1.  New Advances in the Pathogenesis and Pathophysiology of Bacterial Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 2.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis.

Authors:  Ke-Min Chen; Jer-Yuh Liu; Shih-Chan Lai; Li-Sung Hsu; Hsiu-Hsiung Lee
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

4.  Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis.

Authors:  Ke-Min Chen; Hsiu-Hsiung Lee; Hui-Lin Chou; Jer-Yuh Liu; Bo-Cyuan Tsai; Shih-Chan Lai
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

5.  Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Jessica M Hattle; Steven A Dreitz; JoLynn M Troudt; Linda S Izzo; Randall J Basaraba; Ian M Orme; Lynn M Matrisian; Angelo A Izzo
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.

Authors:  H H Lee; H L Chou; K M Chen; S C Lai
Journal:  Parasitol Res       Date:  2004-09-21       Impact factor: 2.289

7.  The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.

Authors:  K P Lan; C J Wang; S C Lai; K M Chen; S S Lee; J D Hsu; H H Lee
Journal:  Parasitol Res       Date:  2004-06-04       Impact factor: 2.289

8.  Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.

Authors:  Yuhsaku Kanoh; Tadashi Ohara; Motonari Kanoh; Tohru Akahoshi
Journal:  Inflammation       Date:  2008-01-10       Impact factor: 4.092

9.  PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling.

Authors:  Kushagra Bansal; Nisha Kapoor; Yeddula Narayana; Germain Puzo; Martine Gilleron; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

10.  Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

Authors:  Justin A Green; Chau T H Tran; Jeremy J Farrar; Mai T H Nguyen; Phu H Nguyen; Sinh X Dinh; Nghia D T Ho; Chuong V Ly; Hien T Tran; Jon S Friedland; Guy E Thwaites
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.